Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    "Sharp syndrome"
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
Conditions: Systemic Lupus Erythematosus;   Rheumatoid Arthritis;   Sharp's Syndrome
Interventions: Other: Intravenous injection of Stromal Vascular Fraction Cells (SVF) containing ADSCs;   Other: Lipoaspiration
2 Recruiting Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
Conditions: Mixed Connective Tissue Disease (MCTD);   Systemic Lupus Erythematosus (SLE)
Intervention:
3 Completed CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
Conditions: Connective Tissue Diseases;   Blood Coagulation Disorders;   Leg Ulcers;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Systemic Scleroderma;   Mixed Connective Tissue Disease
Intervention:
4 Not yet recruiting Role of Mesenchymal Stem Cells in Fat Grafting
Conditions: Romberg's Disease;   Craniofacial Microsomia;   Lipodystrophy;   Mixed Connective Tissue Disease
Interventions: Procedure: Fat graft enriched with ex vivo expanded stem cells;   Procedure: Fat graft not enriched with ex vivo expanded stem cells
5 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
6 Completed The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
7 Terminated
Has Results
A Clinical Trial for CTD-ILD Treatment
Conditions: Interstitial Lung Disease;   Connective Tissue Disease
Intervention: Drug: N-Acetylcysteine
8 Active, not recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
9 Completed Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
10 Unknown  Alendronate Osteoporosis Study
Condition: Glucocorticoid-Associated Osteopenia and Osteoporosis
Intervention: Drug: Alendronate

Indicates status has not been verified in more than two years